Clinical status of the patients
| <3 months post LT | BOS | non-BOS | |
| Patients n | 7 | 4 | 8 |
| Age on the day of bronchoscopy | 41±3 | 43±8 | 42±5 |
| Time since transplant months | 1.4±0.3 | 23.3±8.6 | 15.9±2.3 |
| Sex F:M | 6:1 | 1:3 | 3:5 |
| Underlying disease n | |||
| Emphysema | 2 | 2 | 3 |
| Pulmonary fibrosis | 5 | 1 | 2 |
| Cystic fibrosis | 1 | 1 | |
| Primary pulmonary hypertension | 1 | ||
| Lymphangioleiomyomatosis | 1 | ||
| Type of transplant n | |||
| Single lung | 6 | 3 | 4 |
| Double lung | 1 | 1 | 3 |
| Heart and lung | 1 | ||
| FEV1 before bronchoscopy % of baseline | 99.3±0.6 | 76.0±6.5 | 98.9±2.1 |
| FEF25%–75% before bronchoscopy % of baseline | 99.4±0.5 | 60.5±9.8 | 97.4±0.8 |
| Immunosuppression at the time of bronchoscopy n of patients treated with | |||
| Cyclosporin A/Azathioprin/Prednisolon | 5 | 1 | 0 |
| Cyclosporin A/Mycophenolatmofetil/Prednisolon | 2 | 0 | 0 |
| Tacrolimus/Azathioprin/Prednisolon | 0 | 3 | 8 |
Data are presented as mean±sem unless otherwise stated
LT: lung transplantation
BOS: bronchiolitis obliterans syndrome
F: female
M: male
FEV1: forced expiratory volume in one second
FEF25%–75%: forced midexpiratory flow